Wednesday, January 29, 2020

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.

from Moneycontrol Business News https://ift.tt/2RCYxBJ

No comments:

Post a Comment

F&O Talk| Nifty extends losing streak for 4th week, bearish signals deepen: Sudeep Shah

The Nifty index is on a four-week losing streak, influenced by underwhelming Q1 earnings and global trade concerns. Nifty Bank outperformed ...